TY - JOUR
T1 - Immunotherapy for glioblastoma
T2 - Playing chess, not checkers
AU - Jackson, Christopher M.
AU - Lim, Michael
N1 - Funding Information:
M. Lim reports receiving commercial research grants from Bristol-Myers Squibb and DNATrix and is a consultant/advisory board member for Boston
Publisher Copyright:
© 2018 American Association for Cancer Research.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Patients with glioblastoma (GBM) exhibit a complex state of immune dysfunction involving multiple mechanisms of local, regional, and systemic immunosuppression and tolerance. These pathways are now being identified and their relative contributions explored. Delineating how these pathways are interrelated is paramount to effectively implementing immunotherapy for GBM.
AB - Patients with glioblastoma (GBM) exhibit a complex state of immune dysfunction involving multiple mechanisms of local, regional, and systemic immunosuppression and tolerance. These pathways are now being identified and their relative contributions explored. Delineating how these pathways are interrelated is paramount to effectively implementing immunotherapy for GBM.
UR - http://www.scopus.com/inward/record.url?scp=85052735577&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052735577&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-18-0491
DO - 10.1158/1078-0432.CCR-18-0491
M3 - Article
C2 - 29691293
AN - SCOPUS:85052735577
SN - 1078-0432
VL - 24
SP - 4059
EP - 4061
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 17
ER -